Our Recommendations
New Publications
- Pandemic Influenza Preparedness Framework: 18-month progress report, 1 January 2022–30 June 2023 (2024)
- Case definitions, clinical classification, and disease phases Dengue, Chikungunya, and Zika (2023)
- Public health resource pack for countries experiencing outbreaks of influenza in animals: revised guidance (2023)
- Pandemic influenza preparedness framework: partnership contribution high-level implementation plan III 2024-2030 (2023)
- Australian guidelines for the clinical care of people with MPX (2022)
Filter
107
Featured
Recommendations
26
New Publications
50
Language
Document type
No document type
48
Guidelines
32
Studies & Reports
9
Fact sheets
8
Resource Platforms
4
Training Material
3
Manuals
1
Infographics
1
Online Courses
1
Countries / Regions
Nigeria
6
Guinea
4
Germany
4
Sierra Leone
3
Congo, Democratic Republic of
3
Brazil
3
Liberia
3
Madagascar
3
Senegal
2
Burkina Faso
2
Côte d’Ivoire / Ivory Coast
2
South Africa
2
Rwanda
1
Peru
1
Mozambique
1
Global
1
Dominican Republic
1
Paraguay
1
United Kingdom
1
Mali
1
Angola
1
Authors & Publishers
Publication Years
Category
MPOX - Monkeypox
20
Diarrhoeal Disease/Cholera
9
Yellow Fever
8
Guidelines
7
Yersinia pestis (Plague)
6
Dengue
6
Virology
4
NTDs & Others
4
Pediatrics
3
Vaccine-preventable Diseases
3
Hemorrhagic Fever
3
Zika
2
Paediatrics
2
Emergency Health Kits
2
Clinical Guidelines
2
Diarrhoea
2
Respiratory Infections
2
Disease Prevention & Control
2
Bacteriology
1
x MEDBOX Issue Brief & Annual Reports x
1
General Guidelines
1
NCD
1
WASH
1
Surgery & Anaesthesia
1
Toolboxes
MPOX - Monkeypox
34
Cholera
16
Influenza
12
Cholera Prevention & Control
9
Chikungunya
9
Dengue
8
Treatment Guidelines
7
Yellow Fever
7
Plague
7
Ebola
7
Zika
7
Plague Prevention & Control
5
Clinical Guidelines
4
Treatment Guidelines
4
MOPX - Monkeypox
4
Clinical Guidelines
4
Diarrhoea
4
Outbreak Prevention & Control
3
Ebola Prevention & Control
3
Infection Control
3
Public Health
3
MPOX -Monkeybox Prevention & Control
3
WASH
3
Laboratory & Diagnostics
3
Surveillance
2
Yellow Fever Prevention & Control
2
Influenza Prevention & Control
2
Training
2
Training Material
2
Cholera
2
Emergency health kits
2
Dengue Prevention & Control
2
Other Resources
2
Meningitis & Encephalitis
2
Gynaecology / Obstetrics
1
Communication & Training
1
Laboratory Guidance
1
IPC
1
Context, Facts & Travel Advice
1
Children
1
Key Resources
1
Ebola
1
Laboratory & Sampling
1
PPE Personel Protective Equipment
1
Context & Facts
1
Prevention & Preparedness
1
Risk Communication & Community Engagement
1
Psychosocial Support
1
Essential Medicines & Devices Lists
1
Online Courses
1
Guidelines & Manuals
1
Emergency health kits
1
Dengue & Chikungunya
1
Clinical Aspects & Diagnostics
1
War Surgery & Wound Care
1
Neurological Disorders
1
Zika
1
Malnutrition
1
Clinical Guidelines
1
Chikungunya Prevention & Control
1
Zika Prevention & Control
1
Paediatrics
1
Preparedness & Prevention
1
Case Definitions
1
Pregnant women
1
Public Health
1
Capacity Building
1
Preparedness & Prevention
1
Surveillance, case investigation and contact tracing for monkeypox: interim guidance 24 June 2022
recommended
The overall goal of surveillance, case investigation and contact tracing in this context is to stop human-to-human transmission to control the outbreak. The key objectives of surveillance and case investigation are to rapidly identify cases and clusters in order to provide optimal clinical care; to ...
Laboratory testing for the monkeypox virus
recommended
Any individual that meets the suspected case definition of monkeypox should be offered testing in appropriately equipped laboratories by staff trained in the relevant technical and safety procedures. Confirmation of monkeypox virus infection is based on nucleic acid amplification testing (NAAT), usi...
Clinical features and management of human monkeypox: a retrospective observational study in the UK
recommended
Cases of human monkeypox are rarely seen outside of west and central Africa. There are few data regarding viral kinetics or the duration of viral shedding and no licensed treatments. Two oral drugs, brincidofovir and tecovirimat, have been approved for treatment of smallpox and have demonstrated eff...
Hinweise zur Therapie von Affenpocken
recommended
Therapiehinweise des STAKOB unter Mitwirkung von BfArM, DGI, DGPI, DTG, PEI und Pocken Konsiliarlabor RKI - ZBS 1
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
The Interim Guidance for Risk Communication and Community Engagement (RCCE) outlines recommendations, considerations and methods to raise awareness, manage risk perception, maintain trust and proactively support people at risk to make informed decisions to protect themselves and others from monkeypo...
Presentation
South Africa has recorded its first case of monkeypox today, 23 June 2022. The Minister of
Health Dr. Joe Phaahla explained that he received a report from the National Health
Laboratory Services’ CEO that they have confirmed through laboratory tests the first case of
monkeypox in South Africa. ...
This document summarises the available data on MVA-BN (Imvanex) including from previous
experience of use of this vaccine in contacts of monkeypox cases in the UK and details the
current advice of an expert working group (see Appendix 1 for details) on the use of this vaccine
for pre- and post-ex...
WHO invites Member States, health facilities and other entities to participate in the global effort to collect anonymized clinical data relating to suspected or confirmed cases of monkeypox and contribute data to the WHO Global Clinical Platform.
WHO has developed a clinical characterization case ...
Informationsplattform rund um Affenpocken
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
21 juillet 2022
21 July 2022. The Rapid Core CRF is designed to collect data obtained through examination, interview and review of
hospital or clinic notes of patients with suspected, probable, or confirmed monkeypox infection. Data
may be collected prospectively or retrospectively. The data collection period is ...
Updated August 2022
